title: Tolerance of fondaparinux in patients with generalized contact dermatitis to heparin.
authors.forename: M
authors.initials: M
authors.lastname: Schindewolf
authors.forename: R J
authors.initials: RJ
authors.lastname: Ludwig
authors.forename: M
authors.initials: M
authors.lastname: Wolter
authors.forename: A
authors.initials: A
authors.lastname: Himsel
authors.forename: D
authors.initials: D
authors.lastname: Zgouras
authors.forename: R
authors.initials: R
authors.lastname: Kaufmann
authors.forename: W-H
authors.initials: WH
authors.lastname: Boehncke
authors.forename: E
authors.initials: E
authors.lastname: Lindhoff-Last
mesh_terms: D000368:Aged; D000369:Aged, 80 and over; D000925:Anticoagulants / Q000009:adverse effects* / Q000627:therapeutic use; D016736:Antiphospholipid Syndrome / Q000188:drug therapy; D017449:Dermatitis, Allergic Contact / Q000209:etiology* / Q000473:pathology; D004361:Drug Tolerance; D005260:Female; D000077425:Fondaparinux; D006493:Heparin / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D011134:Polysaccharides / Q000009:adverse effects* / Q000627:therapeutic use; D012867:Skin / Q000473:pathology
chemical_list: D000925:Anticoagulants; D011134:Polysaccharides; D006493:Heparin; D000077425:Fondaparinux